Drug
Cg53135 05
Cg53135 05: highest development phase Phase 2, developed by Celldex Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Celldex Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| CG53135-05, velafermin NCT00104065 | Phase 2 | Stomatitis |
Latest
No recent events.
Follow Cg53135 05 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.